[HTML][HTML] KRAS dimerization impacts MEK inhibitor sensitivity and oncogenic activity of mutant KRAS
The mechanism by which the wild-type KRAS allele imparts a growth inhibitory effect to
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
[引用][C] KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
C Ambrogio, J Köhler, ZW Zhou, H Wang, R Paranal… - Cell, 2018 - cir.nii.ac.jp
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
C Ambrogio, J Köhler, ZW Zhou, H Wang… - Cell, 2018 - pubmed.ncbi.nlm.nih.gov
The mechanism by which the wild-type KRAS allele imparts a growth inhibitory effect to
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.
C Ambrogio, J Köhler, ZW Zhou, H Wang, R Paranal… - Cell, 2018 - europepmc.org
The mechanism by which the wild-type KRAS allele imparts a growth inhibitory effect to
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
[引用][C] KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
C Ambrogio, J Kohler, ZW Zhou, H Wang, R Paranal… - CELL, 2018 - iris.unito.it
[HTML][HTML] KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
C Ambrogio, J Köhler, ZW Zhou, H Wang, R Paranal… - Cell, 2018 - Elsevier
The mechanism by which the wild-type KRAS allele imparts a growth inhibitory effect to
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
KRAS dimerization impacts MEK inhibitor sensitivity and oncogenic activity of mutant KRAS
C Ambrogio, J Köhler, ZW Zhou - Cell, 2018 - dialnet.unirioja.es
The mechanism by which the wild-type KRAS allele imparts a growth inhibitory effect to
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
C Ambrogio, J Köhler, ZW Zhou, H Wang… - …, 2018 - utsouthwestern.elsevierpure.com
The mechanism by which the wild-type KRAS allele imparts a growth inhibitory effect to
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …
oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly …